Main Article Content
Background: Chronic kidney disease (CKD) is a significant public health problem. Dialysis is the mainstream method of treatment in these patients. This causes the patients to have a monotonous and restricted daily life, joint pain, limiting their activities after treatment onset. Hence this study was carried out to find the prevalence of common musculoskeletal disorders in patients undergoing haemodialysis in a tertiary care hospital.
Method: 50 participants undergoing dialysis in a tertiary care hospital under the age group of 18-70 years diagnosed with stage V CKD were included using convenient sampling. They were assessed using Nordic Questionnaire to locate the different areas of pain.
Result: The first group consisted of 41 participants who underwent dialysis from 2- 41 months. Body regions commonly affected in the last 7 days were low back 25(60.97%); neck 21(51.21%); shoulder 15(36.58%); elbow 14(34.14%) in the extremity with arteriovenous fistula; upper back 14(34.14%); hips/thighs, knees 9(21.95); wrist/hands 7(17.07%) in the extremity with arteriovenous fistula; ankle/feet 6(14.63%). The second group consisted of 9 participants who underwent dialysis from 42-84 months. Body regions commonly affected in the last 7 days were low back 8(88.88%); upper back 7(77.77%); hip/thigh 6(66.66%); neck, knee 5(55.55%); elbow 4(44.44%) in the extremity with arteriovenous fistula; shoulder, ankle/feet, wrist/hands 3(33.33%).
Conclusion: The study concluded that the highest prevalence of musculoskeletal disorders in the participants undergoing haemodialysis was low back pain (66%) followed by neck (52%), upper back (42%), shoulder (36%), elbow (36%), hips/thighs (30%), knees (28%), wrist/hands (20%) and ankle/feet pain (18%).
- chronic kidney disease, musculoskeletal disorders, haemodialysis
Copyright (c) 2020 Sanjaitha Jayaprakash, Deepak B. Anap
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
2. Abraham G, Varughese S, Thandavan T, Iyengar A, Fernando E, Naqvi SA, Sheriff R, Ur-Rashid H, Gopalakrishnan N, Kafle RK. Chronic kidney disease hotspots in developing countries in South Asia. Clinical kidney journal. 2016 Feb 1;9(1):135-41.
3. Silva SF, Pereira AA, Silva WA, Simôes R, Neto B, de Resende J. Physical therapy during haemodialysis in patients with chronic kidney disease. Jornal Brasileiro de Nefrologia. 2013 Sep;35(3):170-6.
4. Ding YS, Lo YC, inventors; Baxter Healthcare SA, Baxter International Inc, assignee. Dialysis treatment devices for removing urea. United States patent US 8,404,091. 2013 Mar 26.
5. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. American Journal of Kidney Diseases. 2003 Dec 1;42(6):1239-47.
6. Fainsinger RL, Davison SN, Brenneis C. A supportive care model for dialysis patients. Palliative medicine. 2003;17(1):81.
7. Davison SN. Chronic pain in end-stage renal disease. Advances in chronic kidney disease. 2005 Jul 1;12(3):326-34.
8. Badve SV, Brown F, Hawley CM, Johnson DW, Kanellis J, Rangan GK, Perkovic V. Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nature Reviews Nephrology. 2011 May;7(5):295.
9. Hsu HJ, Yen CH, Hsu KH, Wu IW, Lee CC, Hung MJ, Sun CY, Chou CC, Chen YC, Hsieh MF, Chen CY. Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease. BMC nephrology. 2014 Dec;15(1):6.
10. Caravaca F, Gonzales B, Bayo MÁ, Luna E. Musculoskeletal pain in patients with chronic kidney disease. Nefrología (English Edition). 2016 Jul 1;36(4):433-40.